POL research ethics

(Unterschied zwischen Versionen)
Wechseln zu: Navigation, Suche
Zeile 79: Zeile 79:
 
{{tp|p=32795408|t=2020. Evolving ethics of COVID-19 challenge trials.|pdf=|usr=019}}
 
{{tp|p=32795408|t=2020. Evolving ethics of COVID-19 challenge trials.|pdf=|usr=019}}
 
{{tp|p=32829985|t=2020. SARS-CoV-2 controlled human infection models: Ethics, challenge agent production and regulatory issues.|pdf=|usr=018}}
 
{{tp|p=32829985|t=2020. SARS-CoV-2 controlled human infection models: Ethics, challenge agent production and regulatory issues.|pdf=|usr=018}}
 +
{{tp|p=32840856|t=2020. Coronavirus Human Infection Challenge Studies: Assessing Potential Benefits and Risks.|pdf=|usr=018}}
 +
{{tp|p=32844986|t=2020. Science funding crisis in Brazil and COVID-19: deleterious impact on scientific output.|pdf=|usr=018}}
 +
{{tp|p=32851596|t=2020. COVID-19 vaccines: ethical framework concerning human challenge studies.|pdf=|usr=018}}
 +
{{tp|p=32873550|t=2020. Registering ethnicity for covid-19 research: is the law an obstacle?|pdf=|usr=018}}
 +
{{tp|p=32885370|t=2020. COVID-19: Pitfalls in Offering Research Participation as Therapy in Clinical Settings.|pdf=|usr=018}}
  
 
{{tp|p=32671446|t=2020. Avoiding a Second Wave of Medical Errors: The Importance of Human Factors in the Context of a Pandemic.|pdf=|usr=014}}
 
{{tp|p=32671446|t=2020. Avoiding a Second Wave of Medical Errors: The Importance of Human Factors in the Context of a Pandemic.|pdf=|usr=014}}
  
 
{{tp|p=32511943|t=2020. Retraction-Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.|pdf=|usr=007}}
 
{{tp|p=32511943|t=2020. Retraction-Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.|pdf=|usr=007}}

Version vom 17. Dezember 2020, 17:48 Uhr

  • publication issues will appear in specific threads later currently here
  • virus challenge to be subthreaded later


29412966 2018. Ban on gain-of-function studies ends.
32218549 2020. Should scientists infect healthy people with the coronavirus to test vaccines?
32241929 2020. Infect volunteers to speed a coronavirus vaccine?
32322034 2020. Hundreds of people volunteer to be infected with coronavirus.
32354694 2020. The COVID-19 pandemic, personal reflections on editorial responsibility.
32367890 2020. COVID-19 and Transnational Issues in Copyright and Related Rights.
32373785 2020. Data sharing in the era of COVID-19.
32378373 2020. A publishing pandemic during the COVID-19 pandemic: how challenging can it become?
32378390 2020. Meta-analysis is not always the best way to round out a systematic review: a few thoughts prompted by the COVID-19 pandemic and "spiced-up" with an earthquake.
32379854 2020. Biomedical Research in Times of Emergency: Lessons From History.
32382120 2020. How swamped preprint servers are blocking bad coronavirus research.
32382121 2020. Autopsy slowdown hinders quest to determine how coronavirus kills.
32398241 2020. Waste in covid-19 research.
32402511 2020. COVID-19 Ethics and Research.
32405095 2020. Assessing changes in US public trust in science amid the COVID-19 pandemic.
32407142 2020. Producing Independent, Systematic Review Evidence: Cochrane's Response to COVID-19.
32407155 2020. Publication Ethics During Public Health Emergencies Such as the COVID-19 Pandemic.
32412540 2020. Herausforderungen und Chancen fur die Arbeit der Akademie fur Ethik in der Medizin angesichts der COVID-19-Pandemie.
32413197 2020. Scientific Editing in the COVID-19 Era-Personal Vignettes from the JBMR Editors.
32414291 2020. Fake Science: XMRV, COVID-19, and the Toxic Legacy of Dr. Judy Mikovits.
32422983 2020. No Autopsies on COVID-19 Deaths: A Missed Opportunity and the Lockdown of Science.
32423900 2020. Alarm bells ring for patient data and privacy in the covid-19 goldrush.
32433777 2020. Queries on the COVID-19 quick publishing ethics.
32440022 2020. Scientists baffled by decision to stop a pioneering coronavirus testing project.
32441125 2020. Time-Out Protocol to Ensure Understanding and Implementation of the Storm of Instructions and Protocols During the COVID-19 Pandemic.
32450986 2020. Research and Publishing in the COVID-19 Pandemic.
32457027 2020. Scope, quality, and inclusivity of clinical guidelines produced early in the covid-19 pandemic: rapid review.
32461245 2020. Ethical guidelines for deliberately infecting volunteers with COVID-19.
32464320 2020. 'One more time': why replicating some syntheses of evidence relevant to COVID-19 makes sense.
32467100 2020. Research on covid-19 is suffering "imperfect incentives at every stage".
32469074 2020. Paying Participants in COVID-19 Trials.
32473068 2020. Profile and quality of published reviews on COVID-19.
32479113 2020. Modeling compliance with COVID-19 prevention guidelines: the critical role of trust in science.
32414757 2020. Ethical considerations for epidemic vaccine trials.
32479747 2020. COVID-19 human challenge studies: ethical issues.
32496536 2020. SARS-CoV-2 Human Challenge Trials: Too Risky, Too Soon.
32499292 2020. Covid-19: Validity of key studies in doubt after leading journals issue expressions of concern.
32504015 2020. Will the pandemic permanently alter scientific publishing?
32635912 2020. Exploring the acceptability of controlled human infection with SARSCoV2-a public consultation.
32487103 2020. The crucible of COVID-19: what the pandemic is teaching us about health research systems.
32495919 2020. Representation of specialties in Coronavirus Disease 2019 (COVID-19) research: analysis of published literature in the first 3 months.
32496027 2020. Fast news or fake news?: The advantages and the pitfalls of rapid publication through pre-print servers during a pandemic.
32504025 2020. High-profile coronavirus retractions raise concerns about data oversight.
32636315 2020. Enhancing science preparedness for health emergencies in Africa through research capacity building.
32487369 2020. Balancing the need for rapid and rigorous scientific data during early phase of the COVID-19 pandemic: A further role for the scientific community.


32506512 2020. Redundancy and methodological issues in articles on COVID-19.
32507366 2020. Scientific Publications During the COVID-19 Pandemic.
32532740 2020. Scope, quality, and inclusivity of clinical guidelines produced early in the covid-19 pandemic: rapid review.
32559417 2020. Overcoming fragmentation of health research in Europe: lessons from COVID-19.
32559649 2020. Prejudice in science - Lessons from the coronavirus story.
32575055 2020. Excluding pregnancy from COVID-19 trials: Protection from harm or the harm of protection?
32580894 2020. COVID-19: A time for renewed recognition of science.
32616623 2020. Controlled human infection with SARS-CoV-2 to study COVID-19 vaccines and treatments: bioethics in Utopia.
32641290 2020. Covid-19: The inside story of the RECOVERY trial.
32651163 2020. Covid-19: The inside story of the RECOVERY trial.
32650973 2020. After the pandemic: the role of science in the future of the countries.
32480419 2020. Conquest of COVID-19. Publish it to Death?
32532662 2020. Need for innovative and timely synthesis of evidence during Covid-19 outbreak.
32532663 2020. The eighth alternative to evidence based medicine in the early era of the COVID-19 pandemic: Too much emergency and emotion, too little evidence.
32669183 2020. Why Should SARS-CoV-2 Post-Pandemic Recovery Funding Be Used to Foster a Physician-Scientist Program?
32513798 2020. The good, the bad & the hoax: when publication instantaneously impacts treatment strategies for COVID-19.
32515402 2020. Publishing research during pandemics: are you vulnerable to the COVID-19 or predatory publishers?
32525104 2020. Publishing in the time of pandemic: Editorial policy of a dermatology journal during COVID-19.
32669462 2020. Human Infection Challenge Studies: a Test for the Social Value Criterion of Research Ethics.
32679173 2020. Learning from history: do not flatten the curve of antiviral research!
32690488 2020. Covid-19: Male disadvantage highlights the importance of sex disaggregated data.
32727896 2020. Opinion: Here's how we restore productivity and vigor to the biomedical research workforce in the midst of COVID-19.
32733688 2020. Research ethics in a pandemic: considerations for the use of research infrastructure and resources for public health activities.
32747923 2020. Ethical review of patient safety and public health in EU clinical trials legislation: impact of COVID-19 pandemic.

32769091 2020. Rethinking Gain-of-Function Experiments in the Context of the COVID-19 Pandemic.


32784191 2020. COVID-19 Research: Navigating the European General Data Protection Regulation.
32789282 2020. COVID-19 disparities: An urgent call for race reporting and representation in clinical research.
32789838 2020. Immersive technologies as a solution for general data protection regulation in Europe and impact on the COVID-19 pandemic.
32793374 2020. The use of data from electronic health records in times of a pandemic-a legal and ethical assessment.
32795408 2020. Evolving ethics of COVID-19 challenge trials.
32829985 2020. SARS-CoV-2 controlled human infection models: Ethics, challenge agent production and regulatory issues.
32840856 2020. Coronavirus Human Infection Challenge Studies: Assessing Potential Benefits and Risks.
32844986 2020. Science funding crisis in Brazil and COVID-19: deleterious impact on scientific output.
32851596 2020. COVID-19 vaccines: ethical framework concerning human challenge studies.
32873550 2020. Registering ethnicity for covid-19 research: is the law an obstacle?
32885370 2020. COVID-19: Pitfalls in Offering Research Participation as Therapy in Clinical Settings.


32671446 2020. Avoiding a Second Wave of Medical Errors: The Importance of Human Factors in the Context of a Pandemic.


32511943 2020. Retraction-Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.

Meine Werkzeuge
Namensräume
Varianten
Aktionen
Navigation
Werkzeuge
Blogverzeichnis - Blog Verzeichnis bloggerei.deBlogverzeichnis